Toggle navigation
Home
Search
Services
Blog
Contact
About
Hexokinase II Transcription as Antidiabetic Drugs
Stewart, Alexandria A.
Osi Pharmaceuticals, Inc., Uniondale, NY, United States
Search 8 grants from Alexandria Stewart
Search grants from Osi Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Rf Safety for Ultra-High Field MRI
Genes Underlying the Response to Inhaled Anesthetics
Molecular Basis of Platelet Adhesion
Magnesium in Coronaries-268985155
Development of a Low Energy Neutron Scattering Facility
Recently added grants:
Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational Studies
Targeted Therapy for Endometrial Cancer
Role of FOXO1 mutations in the pathogenesis of B cell non-Hodgkin lymphomas
Overcoming metastatic resistance to ErbB-targeted therapies
Electronic cigarette use in lung cancer patients
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44DK049882-03
Application #
2796589
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (14))
Program Officer
Harmon, Joan T
Project Start
1995-06-15
Project End
2000-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Osi Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Uniondale
State
NY
Country
United States
Zip Code
11553
Related projects
NIH 1999
R44 DK
Hexokinase II Transcription as Antidiabetic Drugs
Stewart, Alexandria A. / Osi Pharmaceuticals, Inc.
NIH 1997
R44 DK
Hexokinase II Transcription as Antidiabetic Drugs
Stewart, Alexander A. / Osi Pharmaceuticals, Inc.
Comments
Be the first to comment on Alexandria Stewart's grant